Understanding the Tests: MRI and Hormone Evaluations
At a Glance
Pituitary stalk interruption syndrome is evaluated with MRI and hormone tests: MRI shows the pituitary’s structure, while blood and stimulation tests assess how each hormone system works. Because deficiencies can appear over time, children need regular follow-up and repeat testing.
Confirming a diagnosis of Pituitary Stalk Interruption Syndrome (PSIS) is a two-part puzzle. First, doctors use imaging to look at the physical structures of the brain. Second, they use specialized blood tests to see how those structures are actually performing. While the MRI provides the “map,” the hormone tests tell us if the “bridge” is carrying the necessary traffic [1][2].
The MRI: Mapping the Anatomy
As discussed in previous pages, the MRI is the primary tool for identifying the physical signs of PSIS. Your child’s radiology report will likely mention several key areas:
- The Pituitary Stalk: Doctors look to see if the stalk is present, thin (hypoplastic), or completely absent [3].
- The Anterior Pituitary: They measure the size of the front lobe of the gland to see if it is smaller than expected (hypoplastic) [1].
- The Ectopic “Bright Spot”: This is the posterior pituitary. In PSIS, it is often found in the wrong place, usually higher up in the brain [1].
- Other Midline Structures: Because the pituitary develops alongside other parts of the brain, doctors also check the optic nerves (for vision), the corpus callosum (which connects the two sides of the brain), and the septum pellucidum [3][4]. Associated findings in these areas may prompt referrals to ophthalmology or developmental specialists.
Important Note: An ectopic “bright spot” does not automatically mean your child will have trouble with water balance (Vasopressin deficiency). The ectopic location does not by itself diagnose the deficiency; function is assessed from thirst, urine output, sodium/osmolality, and specialist evaluation [5][6]. Additionally, MRI anatomy alone cannot perfectly predict exactly which anterior hormones will be deficient.
The Blood Tests: Measuring the “Axes”
The pituitary doesn’t just release one hormone; it controls several different “axes” or pathways. To see if these pathways are working, doctors perform a hormone panel.
| Hormone Axis | What it Controls | Tests That May Be Used |
|---|---|---|
| Growth Axis | Height and growth velocity | Screening: IGF-1 and IGFBP-3. Diagnostic: Dynamic GH stimulation testing. |
| Adrenal Axis | Stress response and blood sugar | Screening: Morning Cortisol. Diagnostic: Specialist-directed adrenal stimulation testing. |
| Thyroid Axis | Metabolism and energy | Free T4 and TSH |
| Gonadal Axis | Puberty and development | LH, FSH, and Testosterone/Estrogen |
| Water Balance | Hydration and urine output | Sodium, Serum/Urine Osmolality |
Why Simple Blood Draws Aren’t Enough
For some hormones, a single blood draw in the morning is sufficient. For example, Free T4 (thyroid) is usually steady enough to measure once [2]. However, hormones like Growth Hormone and Cortisol are released in “pulses” or only when the body is under stress.
A random GH concentration is not a useful standalone diagnostic test. Similarly, a single morning cortisol can be informative but may not exclude central adrenal insufficiency. To get a definitive answer, doctors use stimulation tests (also called dynamic tests). During these tests, your child is given a medication that “challenges” the pituitary to produce a hormone. Doctors then take blood samples over time to see if the gland can rise to the occasion [7][8]. Test choice, timing, and safety are highly individualized; never withhold medications prior to a test unless instructed by your endocrinologist.
The Role of Genetic Testing
Your doctor may offer genetic testing to see if there is a specific mutation causing the PSIS. While this can provide answers for some families, it is important to manage expectations:
- Variable Yield: No single cause is identified in many patients. A negative panel does not exclude a genetic or multifactorial cause [9][4].
- Syndromic Clues: Genetic testing is most helpful if your child has other findings, such as vision problems or extra fingers/toes. Genes like HESX1, LHX4, and OTX2 are sometimes involved [10][4].
- Future Planning: Finding a genetic cause can help with genetic counseling, though most PSIS cases are “sporadic” [2][11].
A Checklist for Parents
Ensure your endocrinology team has evaluated these key areas, especially during the first year of diagnosis:
- Morning Cortisol and ACTH (to screen the life-critical adrenal axis, though a single morning cortisol may not exclude central adrenal insufficiency) [12].
- Free T4 and TSH (to check thyroid function) [12].
- IGF-1 (a supportive marker for growth hormone levels) [12].
- Electrolytes (to check sodium levels and water balance) [13].
- Growth Velocity (tracking height on a specialized chart over several months) [14].
Because PSIS can be “evolving,” a “normal” test today does not mean the axis will always be normal. Regular monitoring is the most important part of the diagnostic process [15][16].
Common questions in this guide
What does an MRI show in pituitary stalk interruption syndrome?
Does an ectopic posterior pituitary bright spot mean my child has water-balance problems?
Why might my child need a stimulation test instead of one blood test?
What hormone tests are usually checked after a PSIS diagnosis?
Can normal hormone results now rule out future problems in PSIS?
Should my child have genetic testing for PSIS?
Get notified when new evidence is published on Pituitary stalk interruption syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Two Cases of Pituitary Stalk Interruption Syndrome in Syrian Children.
Alali I, Saad R, Kabalan Y
Case reports in endocrinology 2020; (2020()):2039649 doi:10.1155/2020/2039649.
PMID: 32231812 - 2
Pituitary stalk interruption syndrome: cause, clinical manifestations, diagnosis, and management.
Voutetakis A, Sertedaki A, Dacou-Voutetakis C
Current opinion in pediatrics 2016; (28(4)):545-50 doi:10.1097/MOP.0000000000000378.
PMID: 27386973 - 3
MRI Features in Children with Pituitary Stalk Interruption Syndrome: Associations with Hormonal Phenotype and Intracranial Anomalies.
Yasar E, Demircan Coskun B, Akin Kagizmanli G, et al.
Academic radiology 2026; doi:10.1016/j.acra.2026.09.057.
PMID: 42892598 - 4
Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohort.
Jullien N, Saveanu A, Vergier J, et al.
Clinical endocrinology 2021; (94(2)):277-289 doi:10.1111/cen.14355.
PMID: 33098107 - 5
Clinical Features and Analysis in Pituitary Stalk Interruption Syndrome.
Guo Q, Zhao J, Yu S
International journal of endocrinology 2024; (2024()):2493083 doi:10.1155/2024/2493083.
PMID: 38828392 - 6
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency.
Sridhar S, Raja BR, Priyanka R, et al.
Pituitary 2023; (26(5)):622-628 doi:10.1007/s11102-023-01351-2.
PMID: 37695468 - 7
Relationship between pituitary stalk (PS) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited.
Wang W, Wang S, Jiang Y, et al.
Clinical endocrinology 2015; (83(3)):369-76 doi:10.1111/cen.12788.
PMID: 25845766 - 8
Pituitary Stalk Interruption Syndrome: A Case and Literature Review.
Choure A, Shahla L
AACE clinical case reports 2025; (11(1)):29-31 doi:10.1016/j.aace.2024.09.007.
PMID: 39896953 - 9
Mutations in the Human ROBO1 Gene in Pituitary Stalk Interruption Syndrome.
Bashamboo A, Bignon-Topalovic J, Moussi N, et al.
The Journal of clinical endocrinology and metabolism 2017; (102(7)):2401-2406 doi:10.1210/jc.2016-1095.
PMID: 28402530 - 10
Pituitary Stalk Interruption Syndrome: From Clinical Findings to Pathogenesis.
Wang CZ, Guo LL, Han BY, et al.
Journal of neuroendocrinology 2017; (29(1)) doi:10.1111/jne.12451.
PMID: 27917547 - 11
Pituitary stalk interruption syndrome.
Voutetakis A
Handbook of clinical neurology 2021; (181()):9-27 doi:10.1016/B978-0-12-820683-6.00002-6.
PMID: 34238482 - 12
Congenital Hypopituitarism.
Parks JS
Clinics in perinatology 2018; (45(1)):75-91 doi:10.1016/j.clp.2017.11.001.
PMID: 29406008 - 13
Causes and Follow-Up of Central Diabetes Insipidus in Children.
Liu W, Hou J, Liu X, et al.
International journal of endocrinology 2019; (2019()):5303765 doi:10.1155/2019/5303765.
PMID: 31049061 - 14
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events.
Diwaker C, Thadani P, Memon SS, et al.
Pituitary 2022; (25(4)):645-652 doi:10.1007/s11102-022-01243-x.
PMID: 35749012 - 15
Pituitary Magnetic Resonance Imaging as a Prognostic Factor of Pituitary Insufficiency-The Follow-Up Analysis of a Cohort of Children With Pituitary Stalk Interruption Syndrome.
Chrzanowska J, Jacków-Nowicka J, Bodetko A, et al.
Clinical endocrinology 2026; (105(2)):231-236 doi:10.1111/cen.70129.
PMID: 41844520 - 16
Clinical evaluation of 31 children with pituitary insufficiency in the course of the pituitary stalk interruption syndrome. The unexpected growth without growth hormone in 2 children.
A Chrzanowska J, Zubkiewicz-Kucharska A, Seifert M, et al.
Pediatric endocrinology, diabetes, and metabolism 2021; (27(4)):272-282 doi:10.5114/pedm.2021.109129.
PMID: 35114769
This page explains MRI and hormone evaluations for a child with PSIS for informational purposes only and does not constitute medical advice. Your child's pediatric endocrinologist should interpret test results and guide the timing and safety of further testing.